Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S1W-04958 · Session 1

Further to the answer to question S1W-3393 by Susan Deacon on 16 February 2000, what plans it has to ensure that individual health boards a…

Answered Asked by Dorothy-Grace Elder SNP Lodged 3 Mar 2000

The question

To ask the Scottish Executive, further to the answer to question S1W-3393 by Susan Deacon on 16 February 2000, what plans it has to ensure that individual health boards are following the Scottish Medical Advisory Committee's guidance about new drugs for multiple sclerosis and clinical advice, issued to all health boards in 1995.

The answer

Answered by Susan Deacon on 31 Mar 2000 · 28 days after it was lodged, 14 days after it was due

The Scottish Medical Advisory Committee's guidance about new drugs for the treatment of relapsing-remitting multiple sclerosis continues to apply. The implementation of that guidance is a matter for each health board.

In the Official Report

No contribution in the Official Report cites S1W-04958 by reference.